Tectonic Therapeutic, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Tectonic Therapeutic, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both fell in each of the last 3 years. Less steady than 96% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 91% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-248.6×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 91% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 0/3Sales and profit both fell in each of the last 3 years.
Less steady than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-48.7×Operating cash was negative last year, while some debt falls due within a year.
Lower than 73% of Healthcare companies in United States.
Cash Cushion Ratio
+61%Cash, after subtracting all debt, equals 61% of its market value (net cash).
Higher than 81% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Tectonic Therapeutic, Inc. made a loss over the last year. Tectonic Therapeutic, Inc. owes $0.06 for every $1 it owns. Tectonic Therapeutic, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTectonic Therapeutic, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.84The share price is 1.84 times Tectonic Therapeutic, Inc.'s book value per share, lower than 61% of Healthcare companies in United States.
Market cap
$412 MThe total market value of all of Tectonic Therapeutic, Inc.'s shares at today's price (share price × number of shares), larger than 52% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$224 MWhat Tectonic Therapeutic, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$11.45Net worth divided by the number of shares. The share price of $21.09 is 1.8 times this, which is the P/B above.
Return on equity (ROE)
-33.8%Tectonic Therapeutic, Inc. lost 33.8% of its shareholders' money over the last year, higher than 59% of Healthcare companies in United States.
Owes vs Owns
0.06×Tectonic Therapeutic, Inc. owes $0.06 for every $1 it owns (low), lower than 96% of Healthcare companies in United States.
Dividend yield
NoneTectonic Therapeutic, Inc. does not currently pay a dividend.
Profit growth
LossTectonic Therapeutic, Inc. made a loss in each of the last two years.
Interest cover
Not coveredTectonic Therapeutic, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashTectonic Therapeutic, Inc. held $253 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Tectonic Therapeutic, Inc.: $412 M ÷ $224 M (30 Jun 2026) = 1.8.
What is Tectonic Therapeutic, Inc.'s return on equity?
Tectonic Therapeutic, Inc. lost 33.8% of its shareholders' money over the last year, higher than 59% of Healthcare companies in United States.
How much does Tectonic Therapeutic, Inc. owe compared with what it owns?
Tectonic Therapeutic, Inc. owes $0.06 for every $1 it owns (low), lower than 96% of Healthcare companies in United States.
Does Tectonic Therapeutic, Inc. pay a dividend?
No. Tectonic Therapeutic, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.